|
Post by peppy on Apr 15, 2019 16:44:42 GMT -5
Refrigeration. Is there any plan to gain a label change in regards to refrigeration and expiration date of Afrezza? If no, why not? I've lost count how many times I've told you directly. To answer your question, there is a plan to change the label in regards to Afrezza's refrigeration expiration. There. Answered. They are working on enhancing Afrezza expiration date by developing a new form of Afrezza that will guarantee stability. With this new technology there will also be other benefits such as larger cartridge doses, ECT. IDK what "ECT" means, but it sure sounds INTERESTING! The next question would be: In regards to Afrezza's refrigeration (expiration), When will Mannkind be able to guarantee stability, and what other implications will come into play by guaranteeing stability? quote: They are working on enhancing Afrezza expiration date by developing a new form of Afrezza that will guarantee stability. reply: That was news to me. good news.
|
|
|
Post by peppy on Apr 15, 2019 16:46:53 GMT -5
The idea that we have should wait until MNKD investor meetings to have our questions answered is a joke. We are a community of investors who converse everyday. If we all shared our questions and answers we received from Mike and not just our gossip and gripes about dumb sh*t - we'd all be better informed. Mike C reads through the board from time to time. The last conference call, I swear I heard him answer most of the questions posted on these threads. regarding waiting for questions to be answered, some SCC rules may pertain. Public information.... stuff.
|
|
johny
Researcher
Posts: 87
|
Post by johny on Apr 15, 2019 16:48:25 GMT -5
I've lost count how many times I've told you directly. To answer your question, there is a plan to change the label in regards to Afrezza's refrigeration expiration. There. Answered. They are working on enhancing Afrezza expiration date by developing a new form of Afrezza that will guarantee stability. With this new technology there will also be other benefits such as larger cartridge doses, ECT. IDK what "ECT" means, but it sure sounds INTERESTING! The next question would be: In regards to Afrezza's refrigeration (expiration), When will Mannkind be able to guarantee stability, and what other implications will come into play by guaranteeing stability? quote: They are working on enhancing Afrezza expiration date by developing a new form of Afrezza that will guarantee stability. reply: That was news to me. good news. *Whispers* This is the wrong thread for this discussion, but yeah Peppy, it was discussed under the FB thread. I don't like dropping names, it tends to hold other people accountable without their knowledge. If you know what I mean...
|
|
johny
Researcher
Posts: 87
|
Post by johny on Apr 15, 2019 16:51:44 GMT -5
The idea that we have should wait until MNKD investor meetings to have our questions answered is a joke. We are a community of investors who converse everyday. If we all shared our questions and answers we received from Mike and not just our gossip and gripes about dumb sh*t - we'd all be better informed. Mike C reads through the board from time to time. The last conference call, I swear I heard him answer most of the questions posted on these threads. regarding waiting for questions to be answered, some SCC rules may pertain. Public information.... stuff. *Whispers* Yeah, I'm DM'ing Liane to remove that.. it didn't need to be said.. we all think differently.
|
|
johny
Researcher
Posts: 87
|
Post by johny on Apr 15, 2019 16:56:11 GMT -5
johny , My interpretation was that you thought members on this board keep information to themselves and don't help fellow members out. I was just standing up for the community knowledge on this board - which has been outstanding. The moderators can't keep out all the "gossip and gripes about dumb sh*t"; we try to be lenient and only moderate for flagrant or repeated violations of the rules. So hopefully we understand each other better. Liane, Oh, I understand, I don't believe anyone withholds information, that wasn't my thought process. Your doing a fine job, and if you wanted to delete that outburst - I'm all for it.
|
|
|
Post by liane on Apr 15, 2019 17:01:01 GMT -5
We're all good.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 15, 2019 17:54:38 GMT -5
Probably unable to answer but, how close is RLS to bringing their product to market?
Has there been interest from other BPs?
UTHR buy in, possible?
Next raise, avoidable?
|
|
|
Post by goyocafe on Apr 15, 2019 17:58:25 GMT -5
Probably unable to answer but, how close is RLS to bringing their product to market? Has there been interest from other BPs? UTHR buy in, possible? Next raise, avoidable? I recall MC stating they were having to cherry pick new opportunities and limit them to only the ones that are well funded. Since that statement, made at least six months ago, I don't believe I've heard another mention of all the cherry picked deals they were entertaining. Maybe one of these hidden gems will pop up out of nowhere before an additional raise is necessary.
|
|
|
Post by ktim on Apr 15, 2019 18:12:27 GMT -5
Probably unable to answer but, how close is RLS to bringing their product to market? Has there been interest from other BPs? UTHR buy in, possible? Next raise, avoidable? If the first RLS API is intended to be FDA approved drug as would seem the case from prior slide presentations, then it is a long way off since trials have not yet started. As for the others, in reality we likely aren't going to have any insight. They will or won't happen, with the former likely appearing from nowhere if they happen and the latter us never becoming aware of. As we've seen in the past Mike talking up the "possibility" of non-dilutive funding doesn't assure it will come to fruition. Whether he says it or not, I'd assume that he's pursuing anything at all credible. Pursuit does not always end up in a catch.
|
|
|
Post by peppy on Apr 15, 2019 18:14:59 GMT -5
Can we, shareholders, please be informed of the RLS milestone schedule? It has been pointed out that the last presentation suggests there are no more development milestones only royalties and sales achievement milestones. this isn't what you were asking for. It is however a look at the medications being worked on. My favorite, seizures disorders and now MS. Not to mention pain. You know what it is to have a miracle cure for these types of seizures. (Insert easter expletive.) Old Woman yelling at a cloud here. "Really, we have been lied to all our lives? Now the ticket is to catch and kill the world's best fast acting insulin?" "Do we have to allow the children to seize so Jeff Sessions can fill the prisons for his pals?" It IS sad.
|
|
|
Post by stockwhisperer on Apr 15, 2019 22:21:35 GMT -5
I've lost count how many times I've told you directly. To answer your question, there is a plan to change the label in regards to Afrezza's refrigeration expiration. There. Answered. They are working on enhancing Afrezza expiration date by developing a new form of Afrezza that will guarantee stability. With this new technology there will also be other benefits such as larger cartridge doses, ECT. IDK what "ECT" means, but it sure sounds INTERESTING! The next question would be: In regards to Afrezza's refrigeration (expiration), When will Mannkind be able to guarantee stability, and what other implications will come into play by guaranteeing stability? quote: They are working on enhancing Afrezza expiration date by developing a new form of Afrezza that will guarantee stability. reply: That was news to me. good news. Question to MNKD... What can MNKD do - recommend to address and put an end to the manipulation that takes place each week via the Friday Script Counting Game. Novices posting wkly sales, refill & revenue data from sources that may or may not be reliable & accurate but ultimately affects the share price, needs to stop.
|
|
|
Post by ktim on Apr 15, 2019 22:35:57 GMT -5
quote: They are working on enhancing Afrezza expiration date by developing a new form of Afrezza that will guarantee stability. reply: That was news to me. good news. Question to MNKD... What can MNKD do - recommend to address and put an end to the manipulation that takes place each week via the Friday Script Counting Game. Novices posting wkly sales, refill & revenue data from sources that may or may not be reliable & accurate but ultimately affects the share price, needs to stop. That would be awful optics for MNKD to try to go after investors sharing script data. I doubt they have any legal standing to do that, however. Everyone knows the script data are estimates, so there is limited accuracy. Investors that put too much emphasis on each weeks numbers, such as buying last week's number and selling this week's number, really probably shouldn't be investing in biotechs because that's a recipe for being an active trader, but buying high and selling low. It's the trends that matter. Trying to protect bad investors from themselves by suppressing data seems ill advised. IMO
|
|
|
Post by stockwhisperer on Apr 15, 2019 23:31:12 GMT -5
Ques to MNKD stands, as is. No one is suggesting they go after investors - quite the contrary. They need to help investors. There has to be a process - suggestion. I doubt any public pharm provides wkly data like this to investors. Not sure wkly Symphony & IMS data is intended for novices. The games being played by novices trying to gather & post this data on a wkly basis, even though it may be intended to be helpful - can and does result in harm to SH’s via manipulation in the share price.
|
|
|
Post by stockwhisperer on Apr 15, 2019 23:41:31 GMT -5
Question for MNKD: Doubt many, if any shareholders want Seeking Alpha’s Spencer Osborne, who arrogantly claims to accurately project sales, revenue, as well as cash and have a better track record than management, to be the continuing, self appointed, weekly voice of MNKD. Clearly, SA can say what they want but what can MNKD do to help protect their shareholders - such as, being more visible, getting in front of this and taking the lead going forward?
|
|
|
Post by ilovekauai on Apr 15, 2019 23:51:38 GMT -5
Just an FYI; at last year's ASM we got like 4 questions in, (if that), and answers were-long winded that quickly veered off-topic. Just saying. It seemed to me at least, that the ASM was a really poor venue to try and get responses. But what do I know; this year could be different; it is after all being held in mid-town Manhattan, my absolute first choice for an ASM where the host company has no anchor. Cheers.
|
|